Combined Chelation Therapy in Patients With Transfusion Dependent Thalassemia and Iron Overload
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
This is a pilot study looking at the safety and efficacy of giving combination chelation with
deferasirox and deferoxamine. The hypothesis is that combination chelation is safe in
decreasing overall iron in patients with thalassemia.
Phase:
Phase 2
Details
Lead Sponsor:
Children's Hospital & Research Center Oakland Elliott Vichinsky